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Abstract
Objective: The ATP-binding cassette transporter A1 (ABCA1) is essential protein involved in lipid metabolism. The
present study was undertaken to detect the possible association of polymorphisms in the ABCA1 gene [rs2230806
(R219K) and rs2230808 (R1587K)] and lipid profile in Greek young nurses.
Methods: The study population consisted of 308 unrelated nurses who were genotyped and the ABCA1
polymorphisms were detected. Additionally, lipid profile [total cholesterol (TC), triglycerides (TGs), high density
lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and apolipoprotein (apo) A] was
evaluated.
Results: There was no difference in the genotypic and allelic frequencies of the R219K polymorphism according to
lipid profile. The R1587K genotypes differed significantly according to TC, LDL-C and TGs concentration (p = 0.023,
p = 0.014 and p = 0.047, respectively). Particularly, significant difference in TC, LDL-C and TGs concentration was
detected between RK and RR genotypes (p = 0.006, p = 0.004, p = 0.014, respectively). Women with RK genotype
compared to RR genotype had higher concentration of TGs (134.25 mg/dl vs 108.89 mg/dl, p = 0.014, respectively),
total cholesterol (207.41 mg/dl vs 187.69 mg/dl, p = 0.006, respectively), and LDL-C (110.6 mg/dl vs 96.9 mg/dl, p =
0.004, respectively).
Conclusions: These findings suggest that the R1587K polymorphism of ABCA1 gene was associated with lipid
profile of Greek nurses. Women with RK genotype had higher TGs, total and LDL-C concentration compared to RR
genotype. These observations may be significant in assessing the risk of CAD since a 1% change in LDL-C is
associated with a 1% change of cardiovascular events. Also, TGs concentration were documented to play a
significant role in women. However, this needs to be confirmed by larger studies.
1. Introduction
The ATP-binding cassette transporter A1 (ABCA1) acts
as a vehicle for cellular cholesterol which after crossing
cell membrane bounds to acceptor molecule such as
apolipoprotein (apo) A [1-3]. Thus, ABCA1 influences
the initial steps in high density lipoprotein (HDL) for-
mation and in reverse cholesterol transport. The
ABCA1 protein belongs to ABC proteins family, which
are ingredients of biological membranes and use ATP to
transfer various particles such as lipids [1]. The ABCA1
protein gene is located in the chromosome 9 in the area
9q31.1. This gene encodes a protein which is expressed
in many tissues such as liver, macrophages, intestines,
lungs etc. Several ABCA1 gene polymorphisms were
identified, including rs2230806 (R219K) and rs2230808
(R1587K), which are mainly associated with the HDL
cholesterol (HDL-C) concentration. The R219K results
i nas i n g l ea m i n oa c i dc h a n g ei nc o d o n2 1 9f r o ma r g i -
nine to lysine. The K allele of the R219K polymorphism
has been related to low coronary artery disease (CAD)
risk [4] and to lower triglycerides (TGs) concentration
[5]. As far as concern the levels of HDL-C the reports
are still confusing [4,6]. The R1587K which is located in
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single amino acid change in codon 1587. This poly-
morphism has been consistently associated with low
HDL-C concentration [7,8].
This study was undergone to evaluate the influence of
these two ABCA1 gene polymorphisms on lipid profile
[total cholesterol, TGs, HDL-C and low density lipopro-
tein cholesterol (LDL-C)] in young nurses. We also
tested if there are any differences in frequency of
ABCA1 gene polymorphisms between individuals with
low and high HDL-C concentration.
2. Materials and methods
Subjects
The genotyping of 308 Greek female students aged 22.5
(±2.3) years who were attended to the University of
Nursing of Technological and Educational Institution
was performed. All students had no personal history of
CAD and were not taking any drugs. Also, exclusion cri-
teria were diabetes mellitus, thyroid and liver disease,
high alcohol consumption, professional athleticism and
any chronic disease.
All women were attended to the University every day
and were staying for 8-10 hours. Women were eating at
the school canteen which served typical Mediterranean
food. Only one (evening) meal daily was most likely to
be different in each student.
Additionally, subject were divided to those with high
(HDL-C >70 mg/dl) and low (HDL-C <40 mg/dl) HDL-
C concentration.
The University of Nursing of Technological and Edu-
cational Institution ethics committee approved the pro-
tocol of this study. All subjects signed an informed
consent form.
Blood Chemistry
Plasma total cholesterol, TGs, HDL-C and apo A1 were
measured using enzymatic colorimetric methods on
Roche Integra Biochemical analyzer with commercially
available kits (Roche). The serum LDL-C concentration
was calculated using the Friedewald formula only in
patients with TGs concentration < 400 mg/dl.
DNA analysis and determination of blood lipids
The ABCA1 gene polymorphisms (R219K and R1587K)
were detected using polymerase chain reaction (PCR)
and restricted fragment length polymorphism analysis
(RFLP’s). The PCR was performed using Taq polymerase
KAPATaq. For R219K polymorphism the oligonucleo-
tide primers which were used are AAAGACTTCAAG-
GACCCAGCTT and CCTCACATTCCGAAAGCATTA
[9]. PCR was subjected to 95°C for 5 min, thirty cycles
of 95°C for 30 s, 55°C for 30 s and 72°C for 30s and
final extension to 72°C for 7 min, producing a fragment
of 309 bp. This fragment was subsequently cleaved by
EcoNI, creating fragments for R allele 309 bp and for K
allele 184 bp and 125 bp, which were subjected to elec-
t r o p h o r e s i so na na g a r o s eg e l4 %a n dv i s u a l i z e dw i t h
ethidium bromide.
For R1587K polymorphism the oligonucleotide primers
which were used are AAGATTTATGACAGGACTGGA-
CACGA and TGAATGCCCCTGCCAACTTTAC [8].
PCR was subjected to 95°C for 5 min, thirty cycles of 95°
C for 30 s, 60°C for 30 s and 72°C for 30s and final exten-
sion to 72°C for 7 min, producing a fragment of 139 bp.
This fragment was subsequently cleaved by BssSI, creat-
ing fragments for R allele 117 bp and 22 bp and for K
allele 139 bp, which were subjected to electrophoresis on
an agarose gel 4% and visualized with ethidium bromide
(Figure 1, Figure 2).
Statistical analysis
The results are given as mean ± standard deviation (SD)
or as median and interquartile range (IQR) according to
normality of continuous variables. All qualitative vari-
ables are presented as absolute or relative frequencies.
All biochemical variables were assessed for normality of
distribution employing the Shapiro-Wilk test and non
parametric statistical tests were used if appropriate.
However, non parametric variables were initially nor-
malized; TGLs by the log10 transformation - apoA1 and
TC by square root transformation and parametric cri-
teria were employed, all providing the same results as
Figure 1 R1587K gene polymorphism.
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mely skewed and we decided to use the median [IQR]
presentation and keep the result of the non parametric
test that was employed.
Differences in lipid levels for the various genotypes
were evaluated with one - way analysis of variance
(ANOVA) or its non-parametric analogue Kruskal -
Wallis H statistic. The Pearson’s chi-square test was
employed for the categorical variables.
All tests were two-tailed and statistical significance
was established at 5% (p < 0.05). Data were analyzed
using Stata™ (Version 10.1 MP, Stata Corporation, Col-
lege Station, TX 77845, USA).
3. Results
Clinical and laboratory parameters
Demographic data, clinical characteristics and lipid pro-
file of the study cohort are shown in Table 1. R and K
allele frequencies appear to have equal distributions in
both ABCA1 polymorphisms (p > 0.05) (Table 2). The
frequencies of R219K genotypes were 50.97% for RR,
40.91% for RK and 8.12% for KK, whereas the frequen-
cies of R1587K genotypes were 47.08% for RR, 41.56%
for RK and 11.36% for KK. Both frequencies were found
in Hardy-Weinberg equilibrium.
R219K and R1587K polymorphisms
The distribution of R219K and R1587K polymorphisms
was investigated according to Low HDL-C (n = 46) and
High HDL-C concentration (n = 104). No statistical differ-
ence was observed in both polymorphisms when com-
pared to Low vs High HDL-C concentration (p = 0.44 and
p = 0.48, respectively). Moreover, no difference in the dis-
tribution of the R219K genotypes was detected according
to lipid profile (Table 2). Also, no differences in the distri-
bution of K and R carriers of R219K polymorphism was
detected according to lipid profile (p = 0.87).
The R1587K genotypes differed significantly according
to total cholesterol, LDL-C and TGs concentration (p =
0.023, p = 0.014 and p = 0.047, respectively) (Table 3). Sig-
nificant difference in LDL-C concentration was detected
between RK and RR genotypes of the same polymorphism
(110.6 mg/dl vs 96.9 mg/dl, respectively, p = 0.004), Figure
3. However, the LDL-C concentration did not differ
between women with the KK and RK genotype of the
R1587K polymorphism (104.52 mg/dl vs 110.64 mg/dl, p
= 0.4). Total cholesterol levels was higher in women with
the RK compared to women with the RR genotype of the
R1587K polymorphism (207.41 mg/dl vs 187.69 mg/dl, p
Figure 2 R219K gene polymorphism.
Table 1 Characteristics of the study population
Demographic data Lipid profile(in mg/dl)
Number of subjects 308 Total Cholesterol 196.6 (59.7)
Age (ys) 22.5 (2.3) TGs 87 [60.5 - 149]
BMI (Kg/m
2) 21.5 [19.8 - 24.2] HDL-C 69.2 (25.9)
Waist (cm) 87.0 (12.5) LDL-C 103.5 (38.8)
Apo A 152.8 (53.5)
Clinical characteristics
Smoking (yes/no) 110/176 (38.5%/61.5%)
HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein
cholesterol, ApoA1: Apolipoprotein A1, TGs: triglycerides. Data are expressed
as mean ± standard deviation (SD) or as median and interquartile range (IQR)
according to normality of continuous variables. Qualitative variables are
presented as absolute and relative frequencies.
Table 2 R and K allele frequencies according to R219K
and R1587K polymorphisms
ABCA1 R allele frequency K allele frequency p value*
R219K 0.72 0.28 0.11
R1587K 0.68 0.32
Fisher’s exact test
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between women with RK and KK genotypes (207.41 mg/dl
vs 193.66 mg/dl, p = 0.22). Finally, a significant difference
was observed in the levels of TGs according to the
R1587K polymorphism, with the RK genotype women
having higher TGs concentration in comparison to the RR
genotype (134.25 mg/dl vs 108.89 mg/dl, p= 0.014). How-
ever, TGs levels did not seem to differ between RK and
KK genotypes of the same polymorphism (134.25 mg/dl vs
108.06 mg/dl, p= 0.11). Also, no differences in the distri-
bution of K and R carriers of R1587K polymorphism was
detected according to lipid profile (p = 0.5).
4. Discussion
We examined the probable impact of the ABCA1 poly-
morphisms as a genetic influence on lipid profile in
Greek young nurses.
R219K gene polymorphism
The frequency of R allele of R219K polymorphism in
o u rs t u d yw a s7 2 %s i m i l a rt oP a s d a re ta l[ 1 0 ]w h o
reported 73.2% in controls (68% in patients with
ischemic stroke) and Porchay et al [11] [D.E.S.I.R parti-
cipants (Data from an Epidemiological Study on the
Insulin Resistance)] who reported 71.7%. Conversely,
Clee et al [5] reported frequency of 46% in Dutch men
with proven CAD who participated in the Regression
Growth Evaluation Statin Study.
Concerning lipid profile, the possibly influence of the
R219K polymorphism is still evaluated. For example,
Hodoğlugil et al in Turks individuals with low HDL-C
concentration found the association of R219K poly-
morphism with HDL-C concentration [12]. Frikke-
Schmidt et al in Danish population did not found any
association between R219K polymorphism and indivi-
duals with Low or High HDL-C concentration [7]. On
the other hand, Kakko et al in Finnish women [13]
found the association of 219K allele with higher HDL-C
concentration. Opposite, Clee et al [5] reported no dif-
ferences according to HDL-C concentration between K
or R allele, although carriers of K allele had significant
lower TGs concentration in relation to carriers of R
allele [5]. Furthermore, younger homozygotes of K allele
had higher cholesterol efflux and HDL-C concentration
compared to homozygotes of R allele. Sandhofer et al
[14] studied male population and did not find any asso-
ciation of R219K polymorphism and lipid profile. Also,
Cenarro et al [15] evaluated the R219K polymorphism
in patients with familial hypercholesterolemia with and
without premature CAD and reported that K allele was
more frequent in subjects without premature CAD com-
pared to individuals with premature CAD [15]. Li et al
[16] investigated the relation of R219K polymorphism
with the manifestation of CAD in Chinese patients and
did not report any significant correlation. However, the
TGs concentration were significant higher and HDL-C
concentration significant lower in patients with RR gen-
otype than those with KK genotype. Similarly, Delgado-
Lista J et al [17] did not find association of R219K
polymorphism and lipid profile.
According to our results from the young Greek female
nurses (living and working in the similar conditions) we
did not find any association with HDL-C concentration
or other lipid parameters. Also, no association between
R219K polymorphism and Low or High HDL-C sub-
groups was found although small number involved in
these groups may be a limitation.
Table 3 Blood lipid levels according to ABCA1 R1587K
polymorphism in all genotypes
Lipid Profile (in mg/dl) Genotype Mean SD P*
RR 187.69 59.19
Total cholesterol RK 207.41 59.55 0.023
KK 193.65 57.49
RR 68.94 26.35
HDL-C RK 69.89 25.33 0.88
KK 67.48 26.57
RR 96.97 38.48
LDL-C RK 110.64 37.26 0.014
KK 104.52 41.51
RR 147.8 53.23
ApoA1 (mg/dl) RK 158.46 54.33 0.26
KK 152.54 50.65
Genotype Median IQR P
†
RR 83 [56 - 123]
TGs RK 98 [63.5 - 180] 0.047
KK 79 [61 - 134]
HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein
cholesterol, ApoA1: Apolipoprotein A1, TGs: triglycerides. *P values among
genotypes from Anova test performance -
†P values among genotypes from
Kruskal Wallis test performance.
Figure 3 Box plot of total cholesterol, LDL-C and TGs
concentration according to R1587K genotypes.
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The frequency of R allele of R1587K polymorphism in
our study was 68%. Pasdar et al [10] reported 75.9% and
Frikke-Schmidt reported 76% [18].
Also, Frikke-Schmidt et al [7] found that this poly-
morphism is overexpresed in individuals (men and
women) with low HDL-C concentration. Furthermore,
there was a gradual decrease in HDL-C levels about
0.07 mmol/l (2.7 mg/dl) for RK genotype and 0.11
mmol/l (4.2 mg/dl) for the RR genotype. Tregouet et al
[19] stated that R1587K has impact on the apo A1 con-
centration. Wang et al [20] did not found any relation
of R1587K with lipids levels in patients with type 2 dia-
betes mellitus who were treated with rozigliatoze. The
study of Clee et al [5] in Danish population has shown
that carriers of K allele had lower HDL-C concentration
in comparison with the KK genotype. In a multi-analysis
including age, BMI, smoking and TGs as independent
variables, the R1587K polymorphism remained signifi-
cant factor for the prediction of HDL-C concentration.
Pasdar et al [10] found the association of R1587K poly-
morphism and apo A concentration and this was not
related to CAD. Cohen et al [21] supported that rare
alleles with major phenotypic effects contribute signifi-
cantly to low HDL-C levels in the general population.
However, Tupitsina et al [9] observed that in patients
with CAD the R1587K polymorphism did not affect
lipids levels. Slatter et al [22] investigated the prevalence
of mutations and common SNPs in ABCA1 in 154 low
HDL-C individuals and 102 high HDL-C individuals.
The R1587K SNP was over represented in low HDL-C
individuals. Ksiazek et al in a small study of 50 indivi-
duals reported a trend (p = 0.07) in terms of association
between TGs concentration and R1587K genotype [23].
In our study no association between R1587K poly-
morphism and HDL-C levels was found. Also, no asso-
ciation between R1587K polymorphism and Low or
High HDL-C subgroups was found. However, indivi-
duals with RK genotype had significantly higher TGs,
total cholesterol and LDL-C concentration compared to
RR genotype.
Reduced circulating HDL-C can be caused by either
genetic and/or environmental factors (sedentary lifestyle,
diabetes mellitus, smoking, obesity or a diet enriched in
carbohydrates). The potential mechanisms of interaction
between genetic variations and phenotypes contribution
are not fully understood. This happens because each
study involved different studying population and the
environmental interactions could not be ruled out.
Thus, in our study the environmental influence was par-
tially diminished. The advantage of our study was that
the study cohort was almost homogenous, since the
nurses most of the time were following the same day to
day program and were eating in the same school
canteen. Thus the influence of diet or physical activities
were unlikely, which may partially explain the lack of
association of R219K or R1587K polymorphisms and
HDL-C concentration. However, the influence of smok-
ing cannot be ruled out since 38.5% of students were
smokers.
It is well known from clinical trials, that 1% change in
LDL-C is associated with a 1% change of cardiovascular
events, which means that individuals born with favorable
genotype (in this case RR genotype of R1587K) have
already some advantage compare to less favorable geno-
types, since they have lower LDL-C. At that time, this
was only a clinical observation. Hopefully in near future
we will be able to identify high risk patients according
to genetic testing, which the assessment in these days
has same cost, time implications and replication pro-
blems in independent studies, which are disadvantages
in routine clinical practice. Nevertheless, these limita-
tions may become less relevant as technology develops.
In summary, the R1587K polymorphism of ABCA1
gene was associated with altered lipid levels in Greek
young nurses. Women with RK genotype had higher
TGs, total and LDL-C concentration compared to RR
genotype. These observations may be significant in
assessing the risk of CAD since a 1% change in LDL-C
is associated with a 1% change of cardiovascular events
and TGs concentration were documented to play a sig-
nificant role in women.
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